Breaking News Instant updates and real-time market news.

CCAP

Crescent BDC

$17.24 /

+0.04 (+0.23%)

09:30
08/12/22
08/12
09:30
08/12/22
09:30

Crescent BDC upgraded to Outperform from Perform at Oppenheimer

Oppenheimer analyst Mitchel Penn upgraded Crescent BDC to Outperform from Perform with a price target of $19, down from $20.

  • 16

    Nov

OTHER BREAKING NEWS FROM THE FLY

Initiation
Vistry Group initiated with an Underweight at Barclays (yesterday) » 13:28
12/02/22
12/02
13:28
12/02/22
13:28
BVHMF

Vistry Group

$6.00 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BVHMF Vistry Group
$6.00 /

+ (+0.00%)

11/07/22 Investec
Vistry Group downgraded to Hold from Buy at Investec
10/20/22 Deutsche Bank
Vistry Group price target lowered to 710 GBp from 1,241 GBp at Deutsche Bank
09/21/22 JPMorgan
Vistry Group downgraded to Underweight from Neutral at JPMorgan
09/12/22 Berenberg
Vistry Group downgraded to Hold from Buy at Berenberg
Initiation
Travis Perkins initiated with an Equal Weight at Barclays (yesterday) » 13:28
12/02/22
12/02
13:28
12/02/22
13:28
TPRKY

Travis Perkins

$11.57 /

+0.36 (+3.21%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPRKY Travis Perkins
$11.57 /

+0.36 (+3.21%)

11/28/22 Exane BNP Paribas
Travis Perkins downgraded to Neutral from Outperform at Exane BNP Paribas
10/24/22 Morgan Stanley
Travis Perkins price target raised to 890 GBp from 855 GBp at Morgan Stanley
10/21/22 RBC Capital
Travis Perkins price target lowered to 1,250 GBp from 1,400 GBp at RBC Capital
10/19/22 Deutsche Bank
Travis Perkins price target lowered to 1,110 GBp at Deutsche Bank
Initiation
Taylor Wimpey initiated with an Overweight at Barclays (yesterday) » 13:27
12/02/22
12/02
13:27
12/02/22
13:27
TWODF

Taylor Wimpey

$1.20 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWODF Taylor Wimpey
$1.20 /

+ (+0.00%)

11/25/22 BofA
Taylor Wimpey downgraded to Underperform from Buy at BofA
10/25/22 Morgan Stanley
Taylor Wimpey price target lowered to 85 GBp from 101 GBp at Morgan Stanley
10/20/22 Deutsche Bank
Taylor Wimpey price target lowered to 115 GBp from 186 GBp at Deutsche Bank
09/21/22 JPMorgan
Taylor Wimpey price target lowered to 170 GBp from 180 GBp at JPMorgan
Hot Stocks
Venus Acquisition Corp trading resumes  13:27
12/02/22
12/02
13:27
12/02/22
13:27
 
Initiation
Redrow initiated with an Overweight at Barclays (yesterday) » 13:27
12/02/22
12/02
13:27
12/02/22
13:27
RDWWF

Redrow

$8.55 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDWWF Redrow
$8.55 /

+ (+0.00%)

11/25/22 BofA
Redrow downgraded to Neutral from Buy at BofA
11/14/22 Citi
Redrow downgraded to Neutral from Buy at Citi
10/20/22 Deutsche Bank
Redrow price target lowered to 499 GBp from 784 GBp at Deutsche Bank
09/21/22 JPMorgan
Redrow downgraded to Neutral from Overweight at JPMorgan
Initiation
Persimmon initiated with an Underweight at Barclays (yesterday) » 13:26
12/02/22
12/02
13:26
12/02/22
13:26
PSMMY

Persimmon

$31.50 /

+0.64 (+2.07%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSMMY Persimmon
$31.50 /

+0.64 (+2.07%)

11/28/22 UBS
Persimmon downgraded to Sell from Neutral at UBS
11/25/22 BofA
Persimmon downgraded to Neutral from Buy at BofA
11/09/22 JPMorgan
Persimmon price target lowered to 2,150 GBp from 2,530 GBp at JPMorgan
10/25/22 Morgan Stanley
Persimmon price target lowered to 1,117 GBp from 1,480 GBp at Morgan Stanley
Initiation
Howden Joinery initiated with an Overweight at Barclays (yesterday) » 13:25
12/02/22
12/02
13:25
12/02/22
13:25
HWDJF

Howden Joinery

$6.99 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HWDJF Howden Joinery
$6.99 /

+ (+0.00%)

09/13/22 JPMorgan
Howden Joinery price target lowered to 660 GBp from 730 GBp at JPMorgan
08/12/22 UBS
Howden Joinery price target lowered to 813 GBp from 1,022 GBp at UBS
06/29/22 JPMorgan
Howden Joinery price target lowered to 730 GBp from 960 GBp at JPMorgan
06/10/22 Berenberg
Howden Joinery price target lowered to 780 GBp from 920 GBp at Berenberg
Initiation
Crest Nicholson initiated with an Equal Weight at Barclays (yesterday) » 13:24
12/02/22
12/02
13:24
12/02/22
13:24
CRTHF

Crest Nicholson

$2.05 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRTHF Crest Nicholson
$2.05 /

+ (+0.00%)

09/21/22 JPMorgan
Crest Nicholson downgraded to Underweight from Neutral at JPMorgan
09/12/22 Berenberg
Crest Nicholson downgraded to Hold from Buy at Berenberg
09/02/22 HSBC
Crest Nicholson downgraded to Hold from Buy at HSBC
05/09/22 Deutsche Bank
Crest Nicholson price target lowered to 415 GBp from 438 GBp at Deutsche Bank
Initiation
Berkeley Group initiated with an Overweight at Barclays (yesterday) » 13:23
12/02/22
12/02
13:23
12/02/22
13:23
BKGFF

Berkeley Group

$43.74 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKGFF Berkeley Group
$43.74 /

+ (+0.00%)

10/20/22 Deutsche Bank
Berkeley Group downgraded to Hold from Buy at Deutsche Bank
09/02/22 HSBC
Berkeley Group downgraded to Reduce from Hold at HSBC
07/08/22 Morgan Stanley
Berkeley Group resumed with an Equal Weight at Morgan Stanley
06/23/22 UBS
Berkeley Group price target lowered to 5,000 GBp from 5,365 GBp at UBS
Initiation
Bellway initiated with an Equal Weight at Barclays (yesterday) » 13:23
12/02/22
12/02
13:23
12/02/22
13:23
BLWYF

Bellway

$18.30 /

+ (+0.00%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLWYF Bellway
$18.30 /

+ (+0.00%)

10/26/22 JPMorgan
Bellway price target raised to 2,660 GBp from 2,640 GBp at JPMorgan
09/21/22 JPMorgan
Bellway price target lowered to 2,640 GBp from 3,230 GBp at JPMorgan
09/12/22 Berenberg
Bellway downgraded to Hold from Buy at Berenberg
09/02/22 HSBC
Bellway downgraded to Hold from Buy at HSBC
Initiation
Barratt Developments initiated with an Overweight at Barclays (yesterday) » 13:22
12/02/22
12/02
13:22
12/02/22
13:22
BTDPY

Barratt Developments

$9.98 /

+0.24 (+2.46%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTDPY Barratt Developments
$9.98 /

+0.24 (+2.46%)

10/26/22 JPMorgan
Barratt Developments price target lowered to 490 GBp from 530 GBp at JPMorgan
10/25/22 Morgan Stanley
Barratt price target lowered to 388 GBp from 449 GBp at Morgan Stanley
10/20/22 Deutsche Bank
Barratt price target lowered to 462 GBp from 835 GBp at Deutsche Bank
09/21/22 JPMorgan
Barratt Developments price target lowered to 530 GBp from 610 GBp at JPMorgan
Recommendations
Spirax-Sarco price target lowered to 9,910 GBp from 11,460 GBp at Jefferies » 13:21
12/02/22
12/02
13:21
12/02/22
13:21
SPXSF

Spirax-Sarco

$133.30 /

+ (+0.00%)

Jefferies analyst Andy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPXSF Spirax-Sarco
$133.30 /

+ (+0.00%)

05/11/22 UBS
Spirax-Sarco price target lowered to 11,110 GBp from 16,100 GBp at UBS
Conference/Events
Vera Therapeutics management to meet with Piper Sandler » 13:20
12/02/22
12/02
13:20
12/02/22
13:20
VERA

Vera Therapeutics

$15.94 /

-0.37 (-2.27%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERA Vera Therapeutics
$15.94 /

-0.37 (-2.27%)

VERA Vera Therapeutics
$15.94 /

-0.37 (-2.27%)

08/22/22 H.C. Wainwright
Vera Therapeutics price target raised to $36 from $35 at H.C. Wainwright
07/12/22 JPMorgan
Vera Therapeutics initiated with an Overweight at JPMorgan
05/02/22 H.C. Wainwright
Vera Therapeutics initiated with a Buy at H.C. Wainwright
04/18/22 Wedbush
Vera Therapeutics initiated with an Outperform at Wedbush
VERA Vera Therapeutics
$15.94 /

-0.37 (-2.27%)

  • 10
    Feb
Conference/Events
First Mid-Illinois Bancshares management to meet virtually with Piper Sandler » 13:19
12/02/22
12/02
13:19
12/02/22
13:19
FMBH

First Mid-Illinois Bancshares

$34.56 /

+0.12 (+0.35%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMBH First Mid-Illinois Bancshares
$34.56 /

+0.12 (+0.35%)

FMBH First Mid-Illinois Bancshares
$34.56 /

+0.12 (+0.35%)

07/07/22 Raymond James
First Mid-Illinois Bancshares upgraded to Outperform from Market Perform at Raymond James
07/07/22 Raymond James
First Mid-Illinois Bancshares upgraded to Outperform from Market Perform at Raymond James
FMBH First Mid-Illinois Bancshares
$34.56 /

+0.12 (+0.35%)

Conference/Events
Newmark management to meet with Piper Sandler » 13:19
12/02/22
12/02
13:19
12/02/22
13:19
NMRK

Newmark

$8.66 /

-0.04 (-0.46%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMRK Newmark
$8.66 /

-0.04 (-0.46%)

NMRK Newmark
$8.66 /

-0.04 (-0.46%)

10/07/22 Piper Sandler
Newmark price target lowered to $10 from $12 at Piper Sandler
04/18/22 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
04/05/22 Goldman Sachs
Newmark initiated with a Neutral at Goldman Sachs
03/10/22 Wolfe Research
Newmark downgraded to Peer Perform from Outperform at Wolfe Research
NMRK Newmark
$8.66 /

-0.04 (-0.46%)

NMRK Newmark
$8.66 /

-0.04 (-0.46%)

Hot Stocks
Venus Acquisition Corp trading halted, volatility trading pause  13:17
12/02/22
12/02
13:17
12/02/22
13:17
 
Technical Analysis
NASDAQ market internals summary » 13:17
12/02/22
12/02
13:17
12/02/22
13:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 13:16
12/02/22
12/02
13:16
12/02/22
13:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
Horizon Pharma put volume heavy and directionally bearish » 13:15
12/02/22
12/02
13:15
12/02/22
13:15
HZNP

Horizon Therapeutics

$104.19 /

+3.31 (+3.28%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HZNP Horizon Therapeutics
$104.19 /

+3.31 (+3.28%)

HZNP Horizon Therapeutics
$104.19 /

+3.31 (+3.28%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
HZNP Horizon Therapeutics
$104.19 /

+3.31 (+3.28%)

HZNP Horizon Therapeutics
$104.19 /

+3.31 (+3.28%)

HZNP Horizon Therapeutics
$104.19 /

+3.31 (+3.28%)

HZNP Horizon Therapeutics
$104.19 /

+3.31 (+3.28%)

Hot Stocks
Baker Hughes reports U.S. rig count unchanged at 784 rigs » 13:02
12/02/22
12/02
13:02
12/02/22
13:02
BKR

Baker Hughes

$29.57 /

+0.31 (+1.06%)

Baker Hughes reports that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKR Baker Hughes
$29.57 /

+0.31 (+1.06%)

BKR Baker Hughes
$29.57 /

+0.31 (+1.06%)

11/18/22 Piper Sandler
Baker Hughes price target raised to $34 from $30 at Piper Sandler
10/26/22 Wells Fargo
Wells Fargo downgrades 'show me' stock Baker Hughes to neutral
10/26/22 Wells Fargo
Baker Hughes downgraded to Equal Weight from Overweight at Wells Fargo
10/20/22 BofA
Baker Hughes price target raised to $32 from $31 at BofA
BKR Baker Hughes
$29.57 /

+0.31 (+1.06%)

BKR Baker Hughes
$29.57 /

+0.31 (+1.06%)

BKR Baker Hughes
$29.57 /

+0.31 (+1.06%)

BKR Baker Hughes
$29.57 /

+0.31 (+1.06%)

Hot Stocks
Baker Hughes reports U.S. rig count unchanged at 784 rigs  13:02
12/02/22
12/02
13:02
12/02/22
13:02
BKR

Baker Hughes

$29.57 /

+0.305 (+1.04%)

 
ShowHide Related Items >><<
BKR Baker Hughes
$29.57 /

+0.305 (+1.04%)

BKR Baker Hughes
$29.57 /

+0.305 (+1.04%)

11/18/22 Piper Sandler
Baker Hughes price target raised to $34 from $30 at Piper Sandler
10/26/22 Wells Fargo
Wells Fargo downgrades 'show me' stock Baker Hughes to neutral
10/26/22 Wells Fargo
Baker Hughes downgraded to Equal Weight from Overweight at Wells Fargo
10/20/22 BofA
Baker Hughes price target raised to $32 from $31 at BofA
BKR Baker Hughes
$29.57 /

+0.305 (+1.04%)

BKR Baker Hughes
$29.57 /

+0.305 (+1.04%)

BKR Baker Hughes
$29.57 /

+0.305 (+1.04%)

BKR Baker Hughes
$29.57 /

+0.305 (+1.04%)

Conference/Events
Piper Sandler global policy analyst to hold analyst/industry conference call » 12:58
12/02/22
12/02
12:58
12/02/22
12:58

Head of Global Policy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Beyond Meat call volume above normal and directionally bullish » 12:45
12/02/22
12/02
12:45
12/02/22
12:45
BYND

Beyond Meat

$14.00 /

-0.35 (-2.44%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$14.00 /

-0.35 (-2.44%)

BYND Beyond Meat
$14.00 /

-0.35 (-2.44%)

11/28/22 Barclays
Beyond Meat downgraded to Underweight from Equal Weight at Barclays
11/23/22 Goldman Sachs
Beyond Meat price target lowered to $5 from $14 at Goldman Sachs
11/10/22 Bernstein
Beyond Meat price target lowered to $10 from $22 at Bernstein
11/10/22 Mizuho
Beyond Meat price target lowered to $11 from $27 at Mizuho
BYND Beyond Meat
$14.00 /

-0.35 (-2.44%)

BYND Beyond Meat
$14.00 /

-0.35 (-2.44%)

BYND Beyond Meat
$14.00 /

-0.35 (-2.44%)

BYND Beyond Meat
$14.00 /

-0.35 (-2.44%)

Conference/Events
JPMorgan consumer/retail analyst holds analyst/industry conference call » 12:45
12/02/22
12/02
12:45
12/02/22
12:45

Retail & Consumer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Digital Brands sees closing Sundry acquisition in next two weeks » 12:34
12/02/22
12/02
12:34
12/02/22
12:34
DBGI

Digital Brands

$3.67 /

+0.28 (+8.26%)

Digital Brands Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DBGI Digital Brands
$3.67 /

+0.28 (+8.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.